SCHEMBL15046475

SCHEMBL15046475

COc1ccc(-c2cn(-c3ccccc3)c(CC(C)=O)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
NPC1 O15118 4/20 0.51
LMNA P02545 3/20 0.51
MAPT P10636 2/20 0.51
GABRA2 P47869 1/20 0.51
GABRB2 P47870 1/20 0.51
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
ALDH1A1 P00352 4/20 0.46
HTT P42858 2/20 0.46
MAPK1 P28482 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
ATM Q13315 1/20 0.44
ALDH1A3 P47895 1/20 0.44
KDM4E B2RXH2 3/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15033985 0.91 SMN1; SMN2 (0.52) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15046451 0.89 MEN1 (0.53) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15046476 0.88 MAPT (0.52) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15033984 0.86 GABRA2 (0.58) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15033980 0.81 MAPT (0.52) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15034550 0.79 RAB9A (0.54) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15043866 0.78 GABRB2 (0.45) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15034552 0.78 GRM5 (0.53) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15046452 0.78 MAPT (0.52) RAB9ASMN1; SMN2NPC1LMNAMAPT
SCHEMBL15034549 0.77 GRM5 (0.47) RAB9ASMN1; SMN2NPC1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013087806-A1 PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 WO disclosed